RE:New Financing has no warrants or conversions to CS'sMake sure to tune in to BNN tomorrow for the special presentation of Short Concordia. Maybe they got an interview with Thompson afterall! Lol
MirrorWorldMan wrote: That means no future dilution and no way shorty can cover. Excellent. Mean EPS will rise every quarter. The 9% is typical BioTech funding rates, based upon future earning potential for new drugs. Much like her. Could not have asked for a better deal as a long.